IntelliAM aiming for significant growth with £5 million Aquis IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,522.50
Bid: 1,522.00
Ask: 1,522.50
Change: 12.00 (0.79%)
Spread: 0.50 (0.033%)
Open: 1,511.50
High: 1,527.00
Low: 1,511.50
Prev. Close: 1,510.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LIVE MARKETS-Inflation, housing market: Same as it ever was

Wed, 13th Jan 2021 16:06

* Major US indexes gyrate, now mixed: Nasdaq, S&P gain, Dow
slips

* Utilities lead S&P sector gainers; materials weakest group

* Euro STOXX 600 edges higher

* Dollar, gold rise; crude dips

* US 10-Year Treasury yield ~1.11%

Jan 13 - Welcome to the home for real-time coverage of
markets brought to you by Reuters reporters. You can share your
thoughts with us at markets.research@thomsonreuters.com

INFLATION, HOUSING MARKET: SAME AS IT EVER WAS (1105
EST/1605 GMT)

U.S. data released on Wednesday shocked exactly no one with
the alarming news that inflation is cool and the housing market
is hot - same song, thousandth verse.

The prices American consumers pay for a basket of items -
the consumer price index (CPI) - increased by 0.4%
in December according to the Labor Department, inline with
consensus and an acceleration from November's 0.2% growth.

The gain was primarily driven by an 8.4% jump in gasoline
prices. Stripping away volatile food and energy prices,
so-called "core CPI" grew by a paltry 0.1%.

Year over year, core CPI growth held firm at 1.6%, well
below the U.S. Federal Reserve's average annual inflation target
of 2%. While the Fed's preferred inflation yardstick is the PCE
index, the languid inflation numbers from nearly every major
indicator suggests the central bank's easy monetary policy isn't
going anywhere for the time being.

"Sluggish aggregate demand keeps underlying price pressures
at bay," writes Kathy Mostjancic, chief U.S. financial economist
at Oxford Economics (OE). "Moreover, the ongoing pandemic
continues to depress gains in core service prices."

It's always a good idea to revisit our old friend The Misery
Index. While the MI takes different forms, it's generally
considered to be the sum of the unemployment rate and annual
inflation growth.

As seen in the graphic below, the MI increased in 2020's
final month for the first time since April:

Finally, demand for home loans jumped by an impressive 16.7%
last week, according to the Mortgage Bankers Association (MBA).

Even with the average 30-year fixed contract rate
inching up 2 basis points to a still-historically-low 2.88%,
refi applications, which accounted for 74.8% of the
total, surged by more than 20%. Demand for loans to purchase
homes rose by 8%.

"Sustained housing demand continued to support purchase
growth, with activity up nearly 10 percent from a year ago,"
said Joel Kan, Associate Vice President of Economic and Industry
Forecasting at MBA.

But can the housing market, the darling of the U.S. economic
recovery, continue its impressive run? Perhaps not.

"We expect some moderation in the pace of home sales from
the late 2020 pace, as rising home prices and limited
inventories constrain sales," says Nancy Vanden Houten, lead
economist at OE.

Investors had difficulty deciding on whether to accentuate
the positive or the negative in morning trading, with the major
U.S. indexes ping-ponging between red and green.

Chips seem determined to have a good day, while
economically sensitive small caps and transports
are easing off Tuesday's record closing highs.

(Stephen Culp)

*****

EUROPEAN STOCKS: UNLOVED FOR THE PAST TWO DECADES, WHAT
ABOUT THE NEXT? (1045 EST/1545 GMT)

While Wall Street and Asian stocks are at all-time highs,
Europe is clearly lagging and has been for the past 20 years.

The old continent's share in the value of global equities
has almost halved over the past two decades, to 17% from over
30%, as per BofA Global Research.

The U.S. bank blames it on the absence of FAANGs, bigger
exposure to cheap sectors like banks and energy, aging
population, pressures from de-globalisation and climate change,
slower GDP growth versus rest of the developed world.

Apparently, Apple sells more watches than the
entire Swiss watch industry, and Cisco's market cap is
more than that of leading telecom service providers in UK,
France, Spain, Italy and Switzerland, combined, according to the
note.

What does the future look like for European investors? BofA
lists a handful of sectors that could shape the markets in the
next decade.

FANGMAN to GRANS: While U.S. remains a FANGMAN
market(Facebook, Amazon, Alphabet,
Microsoft, Apple, Netflix), Europe is
dominated by GRANS (GlaxoSmithKline, Roche,
AstraZeneca, Novartis, Sanofi).
Healthcare has been among the sectors whose markets weightings
have grown in the wake of the pandemic.

CLIMATE ACTION: Eight of the top 10 clean energy companies
by market cap are in Europe, which is also the undisputed leader
of ESG markets.

LUXURY: Luxury companies in Europe are worth more than its
autos sector, while in 2009 they were worth less than one-third;
LVMH is valued more than 4x Daimler, the largest
European carmaker.

GOLDEN AGE FOR EU CLEANTECH: 85% of Europe's electricity is
expected to be from zero-carbon sources by 2030 vs. 57% in 2020;
BofA sees tailwind from economics, policy, funding, tech
innovation and consumer adoption.

Even so, BofA says Europe's pro-cyclical nature and a weak
domestic growth means that European EPS only outperforms during
periods of strong global growth, and it's lack of exposure to
high-growth sectors like technology will drive its structural
underperformance in future.

(Sruthi Shankar)

*****

U.S. STOCKS WAFFLE, THEN HEAD SOUTH (1008 EST/1508 GMT)

Wall Street waffled on Wednesday after the opening bell,
strobing between green then red - but seemed to decide, a
half-hour into the session, to settle in negative territory.

There was little in the way of a catalyst to turn investor
moods sour or sweet. The ongoing vaccine rollout and
expectations for more generous fiscal stimulus from the incoming
Biden administration was again offset by the resurgent pandemic
and the unfolding drama in Washington.

The U.S. House of Representatives is expected to vote for
the second time within 12 months to impeach President Donald
Trump, this time for inciting an insurrection.

That insurrection caught the attention of U.S. Federal
Reserve officials, who said on Tuesday that while concerns about
continued violence pose a risk, but the transition to a new
administration on Jan. 20, and a likely accelerating vaccine
rollout have left them optimistic.

On the economic front, CPI data appeared to confirm tepid
inflation that can keep the Fed's monetary policy accommodative
for the foreseeable future.

In a reversal from Tuesday, economically sensitive small
caps and transports are underperforming the
broader market.

Here's your opening snapshot:
(Stephen Culp)

*****

TECH VS FINANCIALS: COMING BACK TO EARTH (0900 EST/1400 GMT)

After an unprecedented streak of consecutive higher monthly
closes that ended in August of last year, the S&P 500 tech
sector / S&P 500 financial sector ratio has
been coming back to earth.

This, as value took the reins from growth.

Indeed, the tech / financials ratio ended at 5.23 in August,
after having logged 11-straight higher monthly closes. (Click on
chart below)

That's one more month than the 10-month win streak the ratio
recorded into the Nasdaq/tech sector October 2007 top.
It was also this ratio's longest streak of higher monthly closes
using Refinitiv data back to 1989.

Additionally, through August, the ratio ended above its
upper monthly Bollinger Band (BB) for eight straight months
(more than two standard deviations above its 20-month moving
average). That was also its longest such streak going back to
1989. Thus, the ratio appeared especially high on a relative
basis.

With September's downtick, the ratio came back inside the
upper monthly BB, suggesting potential for a more significant
reversal.

Now, at 4.36, the ratio is on track to fall for a 5th
straight month. A continued decline to even just meet the rising
20-month moving average, now around 3.99, would suggest
additional tech underperformance relative to financials, and
with this, likely further growth underperformance vs value.

(Terence Gabriel)

*****

FOR WEDNESDAY'S LIVE MARKETS' POSTS PRIOR TO 0900 EST/1400
GMT - CLICK HERE:

(Terence Gabriel is a Reuters market analyst. The views
expressed are his own)

More News
Today 09:14

LONDON BROKER RATINGS: Jefferies cuts Softcat to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:

Read more
Today 08:33

Citi cuts GSK target price after Arexy disappointment, but stays at 'buy'

(Sharecast News) - Citi has reiterated its 'buy' rating on GSK despite a flurry of disappointing news for the biopharma giant in recent weeks, though the bank has slashed its target price for the stock by more than 10%.

Read more
4 Jul 2024 12:13

UK dividends calendar - next 7 days

Friday 5 July 
abrdn European Logistics Income PLCdividend payment date
Associated British Foods PLCdividend payment date
BlackRock Sustainable American Income Trust PLCdividend payment date
Britvic PLCdividend payment date
Capital Gearing Trust PLCdividend payment date
Computacenter PLCdividend payment date
CT Global Managed Portfolio Trust PLCdividend payment date
Essentra PLCdividend payment date
Forterra PLCdividend payment date
Grainger PLCdividend payment date
Hill & Smith PLCdividend payment date
IntegraFin Holdings PLCdividend payment date
JPMorgan European Growth & Income PLCdividend payment date
Judges Scientific PLCdividend payment date
Likewise Group PLCdividend payment date
Marks & Spencer Group PLCdividend payment date
Marlowe PLCspecial dividend payment date
Menhaden Resource Efficiency PLCdividend payment date
STS Global Income & Growth Trust PLCdividend payment date
TwentyFour Select Monthly Income Fund Ltddividend payment date
US Solar Fund PLCdividend payment date
Warpaint London PLCdividend payment date
Whitbread PLCdividend payment date
WPP PLCdividend payment date
Monday 8 July 
Great Portland Estates PLCdividend payment date
RTC Group PLCdividend payment date
Tuesday 9 July 
Restore PLCdividend payment date
Wednesday 10 July 
abrdn Diversified Income & Growth PLCspecial dividend payment date
Assura PLCdividend payment date
Hollywood Bowl Group PLCdividend payment date
Michelmersh Brick Holdings PLCdividend payment date
National World PLCdividend payment date
Renew Holdings PLCdividend payment date
Thursday 11 July 
Amedeo Air Four Plus Ltdex-dividend payment date
Anpario PLCex-dividend payment date
Atalaya Mining PLCex-dividend payment date
Balanced Commercial Property Trust Ltdex-dividend payment date
BlackRock Latin American Investment Trust PLCex-dividend payment date
Caffyns PLCex-dividend payment date
Cake Box Holdings PLCex-dividend payment date
Caledonia Mining Corp PLCex-dividend payment date
Centrica PLCdividend payment date
Character Group PLCex-dividend payment date
CMC Markets PLCex-dividend payment date
Custodian Property Income REIT PLCex-dividend payment date
Global Smaller Cos Trust PLCex-dividend payment date
Good Energy Group PLCdividend payment date
GSK PLCdividend payment date
Halma PLCex-dividend payment date
Heavitree Brewery PLCex-dividend payment date
Heavitree Brewery PLC Aex-dividend payment date
i3 Energy PLCex-dividend payment date
Invesco Bond Income Plus Ltdex-dividend payment date
JPMorgan Asia Growth & Income PLCex-dividend payment date
JPMorgan Japan Small Cap Growth & Income PLCex-dividend payment date
Kitwave Group PLCex-dividend payment date
Marks Electrical Group PLCex-dividend payment date
Merchants Trust PLCex-dividend payment date
Mountview Estates PLCex-dividend payment date
MS International PLCex-dividend payment date
Oxford Instruments PLCex-dividend payment date
Plus500 Ltddividend payment date
Real Estate Investors PLCex-dividend payment date
Record PLCex-dividend payment date
Sanderson Design Group PLCex-dividend payment date
Schroder European Real Estate Investment Trust PLCex-dividend payment date
Schroder UK Mid Cap Fund PLCex-dividend payment date
Scottish Mortgage Investment Trust PLCdividend payment date
Shoe Zone PLCex-dividend payment date
Supermarket Income REIT PLCex-dividend payment date
Unicorn AIM VCT PLCex-dividend payment date
WH Smith PLCex-dividend payment date
  
Comments and questions to newsroom@alliancenews.com 
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved. 

Read more
3 Jul 2024 09:45

GSK restructures vaccine collaboration with CureVac

(Sharecast News) - GSK announced on Wednesday that it has restructured its collaboration with CureVac into a new licensing agreement, granting GSK exclusive rights to develop, manufacture, and globally commercialise mRNA-based candidate vaccines for influenza and Covid-19.

Read more
3 Jul 2024 09:22

TOP NEWS: GSK inks licensing deal with CureVac for flu and Covid drugs

(Alliance News) - GSK PLC on Wednesday restructured an existing collaboration with CureVac NV into a new licensing agreement to take control of developing a number of flu and Covid drugs.

Read more
3 Jul 2024 09:14

GSK buys COVID, influenza vaccines from retrenching CureVac

July 3 (Reuters) - British drugmaker GSK on Wednesday bought partner CureVac out of their alliance on influenza and COVID-19 vaccine development, boosting its messenger RNA credentials and extending the German biotech company's financial lifeline.

Read more
3 Jul 2024 07:46

LONDON BRIEFING: Keywords Studios agrees takeover by EQT

(Alliance News) - Stocks in London are expected to open higher on Wednesday, as investors shake off pre-election nerves.

Read more
2 Jul 2024 17:24

London close: Stocks fall on EU inflation, US jobs data

(Sharecast News) - London stocks closed lower on Tuesday as investors digested eurozone inflation data and a modest increase in US job openings.

Read more
2 Jul 2024 17:23

London's FTSE 100 hits over two-month low amid election jitters

FTSE 100 down 0.6%, FTSE 250 off 0.1%

*

Read more
1 Jul 2024 23:37

Drugmakers' appeal to end Zantac cancer lawsuits rebuffed by judge

July 1 (Reuters) - A Delaware judge rebuffed a request by GSK and other drugmakers to appeal a ruling allowing more than 70,000 lawsuits claiming that the heartburn drug Zantac caused cancer to go forward.

Read more
28 Jun 2024 19:43

IN BRIEF: GSK reaches settlement over Zantac case in Illinois

GSK PLC - London based pharmaceuticals company - Reaches confidential settlement with Martin Gross resolving the case he filed in Illinois state court regarding Zantac. GSK does not admit any liability in this settlement. The case will now be dismissed as to GSK. Continues to vigorously defend itself and manage this litigation in the best interests of the company and shareholders.

Read more
27 Jun 2024 17:25

European shares subdued ahead of economic data, French elections; H&M plunges

H&M tumbles after missing quarterly profit forecasts

*

Read more
27 Jun 2024 17:02

London's FTSE 100 slips as investors eye US, UK economic data

FTSE 100 down 0.6%, FTSE 250 adds 0.2%

*

Read more
27 Jun 2024 16:40

GSK shares slide after US health agency narrows scope of RSV shots

GSK shares fall as much as 7%

*

Read more
27 Jun 2024 15:48

London close: Stocks mixed ahead of key UK, US data

(Sharecast News) - London stocks ended Thursday's trading session with a mixed performance as market participants awaited crucial US inflation data and UK GDP figures set to be released later in the week.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.